Literature DB >> 8550846

Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies.

S C Liu1, S J Yi, J R Mehta, P E Nichols, S K Ballas, P W Yacono, D E Golan, J Palek.   

Abstract

In red cells from patients with sickle cell anemia, hemoglobin S denatures and forms Heinz bodies. Binding of Heinz bodies to the inner surface of the sickle cell membrane promotes clustering and colocalization of the membrane protein band 3, outer surface-bound autologous IgG and, to some extent, the membrane proteins glycophorin and ankyrin. Loss of transbilayer lipid asymmetry is also found in certain populations of sickle red cells. The lateral distribution of sickle cell membrane lipids has not been examined, however. In this report, we examine by fluorescence microscopy the incorporation and distribution of the fluorescent phospholipid analogues 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD)-phosphatidylserine and NBD-phosphatidylcholine in sickle red cells. Both phospholipid analogues are observed to accumulate prominently at sites of Heinz bodies. Accumulation at sites of Heinz bodies is also shown by 1,'1-dihexadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate, a fluorescent lipid analogue that readily crosses membranes, but not by fluorescein-phosphatidylethanolamine, an analogue that is localized to the outer leaflet of the membrane. Double labeling and confocal microscopy techniques show that NBD-lipids, band 3 protein, protein 4.1, ankyrin, and spectrin are all sequestered within sickle red cells and colocalized at sites of Heinz bodies. We propose that Heinz bodies provide a hydrophobic surface on which sickle red cell membrane lipids and proteins are sequestered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550846      PMCID: PMC507059          DOI: 10.1172/JCI118402

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Protein immunolocalization in the spread erythrocyte membrane skeleton.

Authors:  L H Derick; S C Liu; A H Chishti; J Palek
Journal:  Eur J Cell Biol       Date:  1992-04       Impact factor: 4.492

2.  Uncoupling of the spectrin-based skeleton from the lipid bilayer in sickled red cells.

Authors:  S C Liu; L H Derick; S Zhai; J Palek
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

3.  Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis.

Authors:  F Turrini; P Arese; J Yuan; P S Low
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

Review 4.  The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization.

Authors:  R P Hebbel
Journal:  Semin Hematol       Date:  1990-01       Impact factor: 3.851

Review 5.  Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology.

Authors:  R P Hebbel
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

6.  Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins.

Authors:  E Middelkoop; B H Lubin; E M Bevers; J A Op den Kamp; P Comfurius; D T Chiu; R F Zwaal; L L van Deenen; B Roelofsen
Journal:  Biochim Biophys Acta       Date:  1988-01-22

7.  Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.

Authors:  J D Corbett; D E Golan
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Identification of the eosinyl-5-maleimide reaction site on the human erythrocyte anion-exchange protein: overlap with the reaction sites of other chemical probes.

Authors:  C E Cobb; A H Beth
Journal:  Biochemistry       Date:  1990-09-11       Impact factor: 3.162

9.  Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.

Authors:  E Evans; N Mohandas; A Leung
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

10.  Low density lipoproteins bound to Schistosoma mansoni do not alter the rapid lateral diffusion or shedding of lipids in the outer surface membrane.

Authors:  J P Caulfield; C P Chiang; P W Yacono; L A Smith; D E Golan
Journal:  J Cell Sci       Date:  1991-05       Impact factor: 5.285

View more
  10 in total

1.  The effects of erythrocyte membranes on the nucleation of sickle hemoglobin.

Authors:  Alexey Aprelev; Maria A Rotter; Zipora Etzion; Robert M Bookchin; Robin W Briehl; Frank A Ferrone
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

2.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Authors:  Stéphane M Camus; João A De Moraes; Philippe Bonnin; Paul Abbyad; Sylvain Le Jeune; François Lionnet; Laurent Loufrani; Linda Grimaud; Jean-Christophe Lambry; Dominique Charue; Laurent Kiger; Jean-Marie Renard; Claire Larroque; Hervé Le Clésiau; Alain Tedgui; Patrick Bruneval; Christina Barja-Fidalgo; Antigoni Alexandrou; Pierre-Louis Tharaux; Chantal M Boulanger; Olivier P Blanc-Brude
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

3.  Calculation of a Gap restoration in the membrane skeleton of the red blood cell: possible role for myosin II in local repair.

Authors:  C Cibert; G Prulière; C Lacombe; C Deprette; R Cassoly
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

4.  MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membrane.

Authors:  Alyson S Smith; Kasturi Pal; Roberta B Nowak; Anastasiya Demenko; Carlo Zaninetti; Lydie Da Costa; Remi Favier; Alessandro Pecci; Velia M Fowler
Journal:  Am J Hematol       Date:  2019-04-17       Impact factor: 10.047

5.  Band 3 catalyzes sickle hemoglobin polymerization.

Authors:  Maria A Rotter; Haiyan Chu; Philip S Low; Frank A Ferrone
Journal:  Biophys Chem       Date:  2009-10-19       Impact factor: 2.352

6.  Cross-species malaria immunity induced by chemically attenuated parasites.

Authors:  Michael F Good; Jennifer M Reiman; I Bibiana Rodriguez; Koichi Ito; Stephanie K Yanow; Ibrahim M El-Deeb; Michael R Batzloff; Danielle I Stanisic; Christian Engwerda; Terry Spithill; Stephen L Hoffman; Moses Lee; Virginia McPhun
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

7.  DNA Folding Transition in Presence of Naphthylhydroxamic Acids as Revealed by Fluorescence Microscopic Single Molecule Observation Method.

Authors:  Priyanka Singh; Rama Pande
Journal:  J Fluoresc       Date:  2016-01       Impact factor: 2.217

8.  Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes.

Authors:  Jeff Spector; Gayani C Kodippili; Ken Ritchie; Philip S Low
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

9.  Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.

Authors:  Usman A Tahir; Daniel H Katz; Julian Avila-Pachecho; Clary B Clish; Pradeep Natarajan; Robert E Gerszten; Alexander G Bick; Akhil Pampana; Jeremy M Robbins; Zhi Yu; Zsu-Zsu Chen; Mark D Benson; Daniel E Cruz; Debby Ngo; Shuliang Deng; Xu Shi; Shuning Zheng; Aaron S Eisman; Laurie Farrell; Michael E Hall; Adolfo Correa; Russell P Tracy; Peter Durda; Kent D Taylor; Yongmei Liu; W Craig Johnson; Xiuqing Guo; Jie Yao; Yii-Der Ida Chen; Ani W Manichaikul; Frederick L Ruberg; William S Blaner; Deepti Jain; Claude Bouchard; Mark A Sarzynski; Stephen S Rich; Jerome I Rotter; Thomas J Wang; James G Wilson
Journal:  Nat Commun       Date:  2022-08-22       Impact factor: 17.694

10.  Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia.

Authors:  Lamia M Al-Naama; Mea'ad K Hassan; Jawad K Mehdi
Journal:  Qatar Med J       Date:  2016-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.